CN103768562A - Application of dizziness-relieving and tranquilizing tablet in preparing medicine for inhibiting cell proliferation of leukemia cell L1210 - Google Patents

Application of dizziness-relieving and tranquilizing tablet in preparing medicine for inhibiting cell proliferation of leukemia cell L1210 Download PDF

Info

Publication number
CN103768562A
CN103768562A CN201310670244.6A CN201310670244A CN103768562A CN 103768562 A CN103768562 A CN 103768562A CN 201310670244 A CN201310670244 A CN 201310670244A CN 103768562 A CN103768562 A CN 103768562A
Authority
CN
China
Prior art keywords
rhizoma
ethanol
dizzy
extraction
tranquilizing tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310670244.6A
Other languages
Chinese (zh)
Inventor
孙波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jinan Xinqidian Medical Technology Co Ltd
Original Assignee
Jinan Xinqidian Medical Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jinan Xinqidian Medical Technology Co Ltd filed Critical Jinan Xinqidian Medical Technology Co Ltd
Priority to CN201310670244.6A priority Critical patent/CN103768562A/en
Publication of CN103768562A publication Critical patent/CN103768562A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to application of a dizziness-relieving and tranquilizing tablet in preparing a medicine for inhibiting cell proliferation of a leukemia cell L1210, and a preparation method of the dizziness-relieving and tranquilizing tablet. The dizziness-relieving and tranquilizing tablet is prepared from the following bulk drugs: 400g of pyrola, 160g of epimedium, 160g of astragalus membranaceus, 140g of Chinese angelica, 200g of ligusticum wallichii, 240g of kudzuvine root, 120g of fried bighead atractylodes rhizome, 140g of spina date seed, 120g of prepared pinellia ternate, 120g of rhizoma alismatis, 100g of dried ginger, and 100g of liquorice by adopting supercritical extraction and microwave extraction, so that the content of icariin is greatly improved.

Description

Stop dizzy mind tranquilizing tablet and suppress the application in leukaemia L1210 cell proliferation medicine in preparation
Technical field
The invention belongs to technical field of Chinese medicines, be specifically related to a kind ofly stop dizzy mind tranquilizing tablet and suppress the application in leukaemia L1210 cell proliferation medicine and the preparation method of stopping dizzy mind tranquilizing tablet in preparation.
Background technology
Stop dizzy mind easing standard No. WS-11411(ZD-1411)-2002, be recorded in national standard for traditional Chinese medicines compilation internal medicine taste fascicle.Made as crude drug by Herba Pyrolae 400g, Herba Epimedii 160g, Radix Astragali 160g, Radix Angelicae Sinensis 140g, Rhizoma Chuanxiong 200g, Radix Puerariae 240g, Rhizoma Atractylodis Macrocephalae (parched) 120g, Semen Ziziphi Spinosae 140g, Rhizoma Pinelliae Preparata 120g, Rhizoma Alismatis 120g, Rhizoma Zingiberis 100g, Radix Glycyrrhizae 100g, there is invigorating the liver and kidney, replenishing QI and blood, effect of tranquilizing mind.For deficiency of the liver and kindey, dizzy due to deficiency of both QI and blood, tinnitus, insomnia, cardiopalmus.
In prior art, not yet have and stop dizzy mind easing at the report that suppresses the application in leukaemia L1210 cell proliferation medicine in preparation, also there are no the report that stops dizzy mind easing extraction preparation aspect employing supercritical and microwave technology, and volatile oil extracts, the method that decocting boils, technique is coarse, backward, impurity is many, cause patient's consumption excessive, be inconvenient to take, had a strong impact on this product and applied clinically.
Summary of the invention
Goal of the invention: the object of the present invention is to provide a kind of application of dizzy mind tranquilizing tablet in preparation inhibition leukaemia L1210 cell proliferation medicine that stop.
Another object of the present invention is to provide a kind of preparation method of stopping dizzy mind tranquilizing tablet.
The object of the invention is to realize by following scheme:
Stop dizzy mind tranquilizing tablet and suppress the application in leukaemia L1210 cell proliferation medicine in preparation, describedly stop dizzy mind tranquilizing tablet and made as crude drug by Herba Pyrolae 400g, Herba Epimedii 160g, Radix Astragali 160g, Radix Angelicae Sinensis 140g, Rhizoma Chuanxiong 200g, Radix Puerariae 240g, Rhizoma Atractylodis Macrocephalae (parched) 120g, Semen Ziziphi Spinosae 140g, Rhizoma Pinelliae Preparata 120g, Rhizoma Alismatis 120g, Rhizoma Zingiberis 100g, Radix Glycyrrhizae 100g, described preparation method of stopping dizzy mind tranquilizing tablet is made up of the following step: get Rhizoma Zingiberis, Rhizoma Chuanxiong, Rhizoma Atractylodis Macrocephalae (parched), Radix Angelicae Sinensis, Herba Pyrolae, join CO 2in supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 4-6%, extracting pressure 15-30MPa, temperature 30-50 ℃, CO 2flow l-3ml/g crude drug min, extraction time 300-340min, obtains supercritical extract, for subsequent use; Get all the other Chinese medicines, pulverize, add 6.5L50% ethanol, drop in microwave extracting apparatus and carry out microwave extracting, extraction power 600-800W, extracts 2 times, each 5-10 minute, combining extraction liquid, concentrated, be added on Diaion HP-10 macroporous adsorptive resins, 50% ethanol elution, collects 5 times of amount column volume eluents, decompression recycling ethanol, concentrate and be dried, obtain microwave extraction thing, for subsequent use; Above-mentioned supercritical extract and microwave extraction thing are mixed, add starch, 70% ethanol granule processed, dry, tabletting, makes 200, every heavy 0.5g.
Preferably, the above-mentioned dizzy mind tranquilizing tablet that stops suppresses the application in leukaemia L1210 cell proliferation medicine in preparation, describedly stop dizzy mind tranquilizing tablet and made as crude drug by Herba Pyrolae 400g, Herba Epimedii 160g, Radix Astragali 160g, Radix Angelicae Sinensis 140g, Rhizoma Chuanxiong 200g, Radix Puerariae 240g, Rhizoma Atractylodis Macrocephalae (parched) 120g, Semen Ziziphi Spinosae 140g, Rhizoma Pinelliae Preparata 120g, Rhizoma Alismatis 120g, Rhizoma Zingiberis 100g, Radix Glycyrrhizae 100g, described preparation method of stopping dizzy mind tranquilizing tablet is made up of the following step: get Rhizoma Zingiberis, Rhizoma Chuanxiong, Rhizoma Atractylodis Macrocephalae (parched), Radix Angelicae Sinensis, Herba Pyrolae, join CO 2in supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 5%, extracting pressure 15-30MPa, temperature 30-50 ℃, CO 2flow l-3ml/g crude drug min, extraction time 320min, obtains supercritical extract, for subsequent use; Get all the other Chinese medicines, pulverize, add 6.5L50% ethanol, drop in microwave extracting apparatus and carry out microwave extracting, extraction power 700W, extracts 2 times, each 5-10 minute, combining extraction liquid, concentrated, be added on Diaion HP-10 macroporous adsorptive resins, 50% ethanol elution, collects 5 times of amount column volume eluents, decompression recycling ethanol, concentrate and be dried, obtain microwave extraction thing, for subsequent use; Above-mentioned supercritical extract and microwave extraction thing are mixed, add starch, 70% ethanol granule processed, dry, tabletting, makes 200, every heavy 0.5g.
In prior art, stop each 1 bag of dizzy mind easing, every bag heavy 5g(Sugarless type) or 10g(have sugared type), 3 times on the one.Stop dizzy mind easing dosage large, and granule preparation need to add a large amount of sugar, diabetics is not suitable for, and the words taste of not sugaring is not good, and patient is not easy under clothes, and compliance is poor.Adopt every of the dizzy mind tranquilizing tablet that stops that the inventive method is prepared into weigh 0.5g, only need 2 at every turn, within 1st, take 3 times.Under the condition with more active component, greatly reduce dose.This conclusion can be by following evidence.And be prepared into tablet, patient swallows with water, dosage is little and without bitterness, patient is easy to accept.
The comparison that stops Icariin content in dizzy mind tranquilizing tablet prepared by test one, distinct methods
L, instrument and reagent the present invention stop dizzy mind tranquilizing tablet: by embodiment 1 method preparation, use 2160g crude drug, make 200 through extracting, every heavy 0.5g.Formerly stop dizzy mind easing, according to WS-11411(ZD-1411)-2002 standard methods preparations.Agilent1200 high performance liquid chromatograph; METTLER AE240 electronic analytical balance; Icariin reference substance (Nat'l Pharmaceutical & Biological Products Control Institute).
2, method
Measure according to high performance liquid chromatography (appendix VI D of Chinese Pharmacopoeia version in 2010).
Chromatographic condition and system suitability octadecylsilane chemically bonded silica are filler; Acetonitrile-water (26: 74) is mobile phase; Detection wavelength is 270nm.Number of theoretical plate calculates and should be not less than 8000 by icariin peak.
The preparation precision of reference substance solution takes at 105 ℃ of icariin reference substances that are dried to constant weight appropriate, adds 70% ethanol and makes the solution of every 1ml containing 50 μ g, to obtain final product.
The dizzy mind tranquilizing tablet that stops of the present invention is got in the preparation of need testing solution, and porphyrize, gets 0.4g, accurately weighed, to put in tool plug conical flask, precision adds 70% ethanol 25ml, weighed weight, close plug, placement is spent the night, supersound process 30 minutes, lets cool, more weighed weight, the weight of supplying less loss with 70% ethanol, shakes up, and with microporous filter membrane, (0.45 μ m) filters, get subsequent filtrate, to obtain final product.
The dizzy mind easing of stopping of this contrast is got in the preparation of reference product need testing solution, and porphyrize, gets 4g, put in tool plug conical flask, precision adds 70% ethanol 25ml, weighed weight, close plug, placement is spent the night, supersound process 30 minutes, let cool, more weighed weight, supply the weight of less loss with 70% ethanol, shake up, with microporous filter membrane, (0.45 μ m) filters, and gets subsequent filtrate, to obtain final product.
Algoscopy is accurate reference substance solution and the each 20 μ l of need testing solution of drawing respectively, and injection liquid chromatography, measures, and to obtain final product.
3, result
Result shows, the content that the present invention stops icariin in dizzy mind tranquilizing tablet is 3.5-6g/ sheet; And the former content that stops icariin in dizzy mind easing is 1.2mg/ bag, be 6-10 times of former granule content each serving the Icariin content of 2 of consumptions, in the situation that dose reduces, Icariin content improves a lot.
Above-mentioned research shows, adopts the dizzy mind tranquilizing tablet that stops prepared by preparation method of the present invention, and active constituent content is far away higher than WS-11411(ZD-1411) method recorded of-2002 standards prepare stop dizzy mind easing.
The specific embodiment
Below in conjunction with specific embodiment, the present invention is further described, so that those skilled in the art more understands the present invention, but this should be interpreted as to the scope of the above-mentioned theme of the present invention only limits to following example, all technology realizing based on foregoing of the present invention all belong to scope of the present invention.
Embodiment 1
Get Herba Pyrolae 400g, Herba Epimedii 160g, Radix Astragali 160g, Radix Angelicae Sinensis 140g, Rhizoma Chuanxiong 200g, Radix Puerariae 240g, Rhizoma Atractylodis Macrocephalae (parched) 120g, Semen Ziziphi Spinosae 140g, Rhizoma Pinelliae Preparata 120g, Rhizoma Alismatis 120g, Rhizoma Zingiberis 100g, Radix Glycyrrhizae 100g, Rhizoma Zingiberis, Rhizoma Chuanxiong, Rhizoma Atractylodis Macrocephalae (parched), Radix Angelicae Sinensis, Herba Pyrolae are joined to CO 2in supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 5%, extracting pressure 25MPa, 40 ℃ of temperature, CO 2flow 2ml/g crude drug min, extraction time 320min, obtains supercritical extract, for subsequent use; Get all the other Chinese medicines, pulverize, add 6.5L50% ethanol, drop in microwave extracting apparatus and carry out microwave extracting, extraction power 700W, extracts 2 times, each 8 minutes, combining extraction liquid, concentrated, be added on Diaion HP-10 macroporous adsorptive resins, 50% ethanol elution, collects 5 times of amount column volume eluents, decompression recycling ethanol, concentrate and be dried, obtain microwave extraction thing, for subsequent use; Above-mentioned supercritical extract and microwave extraction thing are mixed, add starch, 70% ethanol granule processed, dry, tabletting, makes 200, every heavy 0.5g.
After testing, in finished product, the content of icariin is 5.9mg/ sheet.
Embodiment 2
Get Herba Pyrolae 400g, Herba Epimedii 160g, Radix Astragali 160g, Radix Angelicae Sinensis 140g, Rhizoma Chuanxiong 200g, Radix Puerariae 240g, Rhizoma Atractylodis Macrocephalae (parched) 120g, Semen Ziziphi Spinosae 140g, Rhizoma Pinelliae Preparata 120g, Rhizoma Alismatis 120g, Rhizoma Zingiberis 100g, Radix Glycyrrhizae 100g, Rhizoma Zingiberis, Rhizoma Chuanxiong, Rhizoma Atractylodis Macrocephalae (parched), Radix Angelicae Sinensis, Herba Pyrolae are joined to CO 2in supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 4%, extracting pressure 30MPa, temperature 50 C, CO 2flow 3ml/g crude drug min, extraction time 300min, obtains supercritical extract, for subsequent use; Get all the other Chinese medicines, pulverize, add 6.5L50% ethanol, drop in microwave extracting apparatus and carry out microwave extracting, extraction power 600W, extracts 2 times, each 5 minutes, combining extraction liquid, concentrated, be added on Diaion HP-10 macroporous adsorptive resins, 50% ethanol elution, collects 5 times of amount column volume eluents, decompression recycling ethanol, concentrate and be dried, obtain microwave extraction thing, for subsequent use; Above-mentioned supercritical extract and microwave extraction thing are mixed, add starch, 70% ethanol granule processed, dry, tabletting, makes 200, every heavy 0.5g.
After testing, in finished product, the content of icariin is 3.6mg/ sheet.
Embodiment 3
Get Herba Pyrolae 400g, Herba Epimedii 160g, Radix Astragali 160g, Radix Angelicae Sinensis 140g, Rhizoma Chuanxiong 200g, Radix Puerariae 240g, Rhizoma Atractylodis Macrocephalae (parched) 120g, Semen Ziziphi Spinosae 140g, Rhizoma Pinelliae Preparata 120g, Rhizoma Alismatis 120g, Rhizoma Zingiberis 100g, Radix Glycyrrhizae 100g, Rhizoma Zingiberis, Rhizoma Chuanxiong, Rhizoma Atractylodis Macrocephalae (parched), Radix Angelicae Sinensis, Herba Pyrolae are joined to CO 2in supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 6%, extracting pressure 15MPa, 30 ℃ of temperature, CO 2flow 1ml/g crude drug min, extraction time 340min, obtains supercritical extract, for subsequent use; Get all the other Chinese medicines, pulverize, add 6.5L50% ethanol, drop in microwave extracting apparatus and carry out microwave extracting, extraction power 800W, extracts 2 times, each 10 minutes, combining extraction liquid, concentrated, be added on Diaion HP-10 macroporous adsorptive resins, 50% ethanol elution, collects 5 times of amount column volume eluents, decompression recycling ethanol, concentrate and be dried, obtain microwave extraction thing, for subsequent use; Above-mentioned supercritical extract and microwave extraction thing are mixed, add starch, 70% ethanol granule processed, dry, tabletting, makes 200, every heavy 0.5g.
After testing, in finished product, the content of icariin is 4.5mg/ sheet.
Embodiment 4: stop the experimentation data that dizzy mind tranquilizing tablet suppresses mouse leukemia cell L1210 cell proliferation
1. experiment material
1.1 experiment cell strains
Mouse leukemia cell L1210 cell, Shandong University's laboratory cell bank, DMEM+10%FBS cellar culture.
1.2 Experimental agents
Drugs: the present invention stops dizzy mind tranquilizing tablet: by embodiment 1 method preparation.
Medicinal liquid liquid storage: take 100mg and stop dizzy mind tranquilizing tablet, be dissolved in 5ml dehydrated alcohol, 0.2 μ m filter filters, 500 μ ldoff pipe subpackages ,-20 ℃ of storages, 0.2 μ m filter filters the use of dehydrated alcohol in order to matched group simultaneously.
1.3 experiment reagent
DMEM (the Cat.No.12100-061 Lot.No.758137 of GIBCO company); Hyclone (Lot.No.100419 of Tian Hang bio tech ltd, Zhejiang); NaHC0 3(the Shanghai hundred million Cat.No.11810-033 Lot.No.1088387 of chemical reagent company limited of a specified duration); Trypsin(AMRESCO company); EDTA(AMRESCO company); Penicillin G Sodium Salt(AMRESCO company 1); Streptomycin Sulfate (AMRESCO); Dehydrated alcohol (Zibo Ya Dulan Trade Co., Ltd.); MTT (Biosharp lot number: 0793): PBS(laboratory autogamy);
1.4 experiment equipment
Lycra inverted microscope (German Leica model: DMIL); Visible-ultraviolet light microwell plate detector (MD company of U.S. model: SPECTRAMAX 190); C0 2incubator (FORMA model: 3111); Super-clean bench (safe and sound company of Su Jing group manufactures model: SW-CJ-ZFD); Pure water instrument (Sprlng company of U.S. model: S/N 020579); Accurate pipettor (French Gilson Inc model: P2); Electronic balance (German Sai Duolisi company limited model: BT323S); Full-automatic high-pressure autoclave (Japanese SANYO company model: MLS-3020); Table electrothermal air dry oven (Shanghai accurate experimental facilities company model: DHG9123A); Refrigerator (Siemens Company's model: KG18V21TI); Liquid nitrogen container (CBS model: 2001); Low speed centrifuge (Anting Scientific Instrument Factory, Shanghai's model: KA-1000); 0.2 μ m filter (MILLIPORE model: SLGP033RB); 1cm culture dish (NEST company), 96 well culture plates (NEST company); Cell counting count board; Centrifuge tube, pipet, Tips are some.
2. experimental technique
1) L1210 cell uses DMEM+10%FBS in 37 ℃, 5%C0 2carry out cellar culture (10cm culture dish), when Growth of Cells is during to logarithmic (log) phase, collecting cell, discards culture fluid, PBS fine laundering 3 times, add 3ml 0.25% trypsin-0.04%EDTA, after 37 ℃ of digestion 2min, add wherein 5ml complete medium neutralization reaction, after piping and druming cell, proceeded in centrifuge tube, the centrifugal 5min of 1000rpm, adjusts concentration of cell suspension 3 × 10 4individual/ml.
2) cell kind is entered in 96 well culture plates, every hole adds cell suspension 180 μ l, culture plate put into cell culture incubator (37 ℃, 5%C0 2) cellar culture.
3) according to Growth of Cells situation, generally grow to 50%-70%, add and stop dizzy mind tranquilizing tablet solution, continue to cultivate 24h.
4) after 24h, add 20 μ l MTT solution (5mg/ml, i.e. 0.5%MTT), continue to cultivate 4h.
5) after 4h, buckle method is removed supernatant, pats dry gently with absorbent paper, and low-speed oscillation 10min on shaking table, as entered 200 μ l dimethyl sulfoxide, is put in every hole, and crystal is fully dissolved.Measure the light absorption value in each hole at enzyme-linked immunosorbent assay instrument 490nm place.
6) background (do not add cell, only add culture fluid) is set simultaneously, control wells (the medicine dissolution medium of cell, same concentrations, culture fluid, MTT, dimethyl sulfoxide), sets 6 multiple holes for every group.
7) result represents the suppression ratio of cell with medicine: cell increment suppression ratio (%)=(control wells OD value-dosing holes OD value), control wells OD value × 100%.Experiment repeats 3 times.
3. statistical disposition
Adopt correlation analysis and Student t check in Microsoft Excel 2007 softwares, data represent with mean ± SD.
4. experimental result
Statistical result showed after mtt assay experiment, with matched group comparison, in the time that dosage reaches 5mg/ml, to L1210 cell inhibitory effect variant (P<0.05), dosage this difference in the time of 10mg/ml has significance (P<0.01), has utmost point significant difference (P<0.001) in the time that dosage reaches 15-20mg/ml.
Table 1 stops dizzy mind tranquilizing tablet to L1210 cell inhibitory effect impact research (X ± SD)
Group Drug level (mg/ml) Suppression ratio (%)
Matched group 0 0
1 5 12.29±5.72
2 10 21.46±8.53*
3 15 35.39±12.64**
4 20 45.87±16.98**
Note: with matched group comparison, * P<O.01; * P<0.001.
5. experiment conclusion
Of the present inventionly stop dizzy mind tranquilizing tablet and can suppress L1210 cell proliferation, reduce the Growth of Cells number of L1210 cell, this effect is dose dependent.

Claims (2)

1. stop dizzy mind tranquilizing tablet and suppress the application in leukaemia L1210 cell proliferation medicine in preparation, describedly stop dizzy mind tranquilizing tablet and made as crude drug by Herba Pyrolae 400g, Herba Epimedii 160g, Radix Astragali 160g, Radix Angelicae Sinensis 140g, Rhizoma Chuanxiong 200g, Radix Puerariae 240g, Rhizoma Atractylodis Macrocephalae (parched) 120g, Semen Ziziphi Spinosae 140g, Rhizoma Pinelliae Preparata 120g, Rhizoma Alismatis 120g, Rhizoma Zingiberis 100g, Radix Glycyrrhizae 100g, it is characterized in that, described preparation method of stopping dizzy mind tranquilizing tablet is made up of the following step: get Rhizoma Zingiberis, Rhizoma Chuanxiong, Rhizoma Atractylodis Macrocephalae (parched), Radix Angelicae Sinensis, Herba Pyrolae, join CO 2in supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 4-6%, extracting pressure 15-30MPa, temperature 30-50 ℃, CO 2flow l-3ml/g crude drug min, extraction time 300-340min, obtains supercritical extract, for subsequent use; Get all the other Chinese medicines, pulverize, add 6.5L50% ethanol, drop in microwave extracting apparatus and carry out microwave extracting, extraction power 600-800W, extracts 2 times, each 5-10 minute, combining extraction liquid, concentrated, be added on Diaion HP-10 macroporous adsorptive resins, 50% ethanol elution, collects 5 times of amount column volume eluents, decompression recycling ethanol, concentrate and be dried, obtain microwave extraction thing, for subsequent use; Above-mentioned supercritical extract and microwave extraction thing are mixed, add starch, 70% ethanol granule processed, dry, tabletting, makes 200, every heavy 0.5g.
2. suppress the application in leukaemia L1210 cell proliferation medicine according to the dizzy mind tranquilizing tablet that stops described in claim l in preparation, describedly stop dizzy mind tranquilizing tablet and made as crude drug by Herba Pyrolae 400g, Herba Epimedii 160g, Radix Astragali 160g, Radix Angelicae Sinensis 140g, Rhizoma Chuanxiong 200g, Radix Puerariae 240g, Rhizoma Atractylodis Macrocephalae (parched) 120g, Semen Ziziphi Spinosae 140g, Rhizoma Pinelliae Preparata 120g, Rhizoma Alismatis 120g, Rhizoma Zingiberis 100g, Radix Glycyrrhizae 100g, it is characterized in that, described preparation method of stopping dizzy mind tranquilizing tablet is made up of the following step: get Rhizoma Zingiberis, Rhizoma Chuanxiong, Rhizoma Atractylodis Macrocephalae (parched), Radix Angelicae Sinensis, Herba Pyrolae, join CO 2in supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 5%, extracting pressure 15-30MPa, temperature 30-50 ℃, CO 2flow l-3ml/g crude drug min, extraction time 320min, obtains supercritical extract, for subsequent use; Get all the other Chinese medicines, pulverize, add 6.5L50% ethanol, drop in microwave extracting apparatus and carry out microwave extracting, extraction power 700W, extracts 2 times, each 5-10 minute, combining extraction liquid, concentrated, be added on Diaion HP-10 macroporous adsorptive resins, 50% ethanol elution, collects 5 times of amount column volume eluents, decompression recycling ethanol, concentrate and be dried, obtain microwave extraction thing, for subsequent use; Above-mentioned supercritical extract and microwave extraction thing are mixed, add starch, 70% ethanol granule processed, dry, tabletting, makes 200, every heavy 0.5g.
CN201310670244.6A 2013-12-10 2013-12-10 Application of dizziness-relieving and tranquilizing tablet in preparing medicine for inhibiting cell proliferation of leukemia cell L1210 Pending CN103768562A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310670244.6A CN103768562A (en) 2013-12-10 2013-12-10 Application of dizziness-relieving and tranquilizing tablet in preparing medicine for inhibiting cell proliferation of leukemia cell L1210

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310670244.6A CN103768562A (en) 2013-12-10 2013-12-10 Application of dizziness-relieving and tranquilizing tablet in preparing medicine for inhibiting cell proliferation of leukemia cell L1210

Publications (1)

Publication Number Publication Date
CN103768562A true CN103768562A (en) 2014-05-07

Family

ID=50561622

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310670244.6A Pending CN103768562A (en) 2013-12-10 2013-12-10 Application of dizziness-relieving and tranquilizing tablet in preparing medicine for inhibiting cell proliferation of leukemia cell L1210

Country Status (1)

Country Link
CN (1) CN103768562A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102988723A (en) * 2012-10-08 2013-03-27 李正梅 Preparation method and application of yin tonifying and calming tablet

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102988723A (en) * 2012-10-08 2013-03-27 李正梅 Preparation method and application of yin tonifying and calming tablet

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
国家药品监督管理局: "止眩安神颗粒", 《国家药品标准(试行)颁布件》 *

Similar Documents

Publication Publication Date Title
CN103690646B (en) Preparation method of Yikangbuyuan tablet and application of Yikangbuyuan tablet in medicine for inhibiting mouse lymphoma cell YAC-1 cell proliferation
CN103655843B (en) A kind of Yikang complement sheet and its preparation method and application
CN103638450B (en) A kind of preparation method of Muxiangliqi Tablet and application
CN103690647B (en) A kind of preparation method of Yikang complement sheet and the application in suppression mouse leukemia cell L6565 cell proliferation thereof
CN103800871A (en) Application of dizziness-relieving and calming tablet in preparing medicine for inhibiting cell proliferation of embryonal carcinoma cell F9
CN103655842B (en) Preparation method of Yikangbuyuan tablet and application of Yikangbuyuan tablet in medicines for inhibiting mouse lymphomata cell EL4. IL-2 proliferation
CN103655839B (en) Preparation method of Yikangbuyuan tablet and application of Yikangbuyuan tablet in medicines for inhibiting mouse lung cancer cell LLC proliferation
CN103655841B (en) Preparation method of Yikangbuyuan tablet and application of Yikangbuyuan tablet in medicines for inhibiting mouse lymphoid cancer cell P388D1 proliferation
CN103735960A (en) Application of boenninghausenia sessilicarpa cough-asthma tablet to prepare medicaments for inhibiting lung cancer cell LLC proliferation
CN103800498A (en) Preparation method of Qingmei cold tablet and application of Qingmei cold tablet in drugs for inhibiting mouse prostate cancer cell RM-1 from cell proliferation
CN103768266A (en) Preparation method of Qingmei cold tablet and application of Qingmei cold tablet in drugs for inhibiting mouse leukaemia cell L6565 from cell proliferation
CN103800499A (en) Preparation method of Qingmei cold tablet and application of Qingmei cold tablet in drugs for inhibiting melanoma cell B16 from cell proliferation
CN103768263A (en) Preparation method of Qingmei cold tablet and application of Qingmei cold tablet in drugs for inhibiting cerebral nerve oncocyte Neuro-2a from cell proliferation
CN103751424A (en) Preparation method of cold tablet containing Artemisia carvifolia and holly root, and application of cold tablet in teratoma cell F9 cell proliferation inhibition medicines.
CN103768562A (en) Application of dizziness-relieving and tranquilizing tablet in preparing medicine for inhibiting cell proliferation of leukemia cell L1210
CN103768561A (en) Application of dizziness-relieving and tranquilizing tablet in preparing medicine for inhibiting cell proliferation of lymphoma cell EL4
CN103655840B (en) Preparation method of Yikangbuyuan tablet and application of Yikangbuyuan tablet in medicines for inhibiting mouse leukaemia cell L1210 proliferation
CN103800872A (en) Application of anti-dizziness calming tablet to preparation of medicament for inhibiting cranial nerve oncocyte Neuro-2a cell proliferation
CN103655838B (en) Preparation method of Yikangbuyuan tablet and application of Yikangbuyuan tablet in medicines for inhibiting mouse lymphomata cell L5178Y proliferation
CN103800770A (en) Application of boenninghausenia cough tablet in preparing medicine for inhibiting cell proliferation of breast tumor cell C127
CN104288658A (en) Preparation method of fomes officinalis cough and asthma treating tablets and application of fomes officinalis cough and asthma treating tablets in preparation of medicine for inhibiting cell proliferation of mouse myeloma cell SP2/0
CN103768264A (en) Preparation method of Qingmei cold tablet and application of Qingmei cold tablet in drugs for inhibiting teratoma cell P19 from cell proliferation
CN103768207A (en) Preparation method of Qingmei cold tablet and application of Qingmei cold tablet in drugs for inhibiting lung cancer cell Hepa1-6 from cell proliferation
CN103800569A (en) Preparation method of Qingmei cold tablet and application of Qingmei cold tablet in drugs for inhibiting lymphoma cell YAC-1 from cell proliferation
CN103751350A (en) Preparation method of Qingmei cold-treatment tablet and use of Qingmei cold-treatment tablet in drug for inhibiting leukemia cell L1210 proliferation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20140507

RJ01 Rejection of invention patent application after publication